404: Page not Found

To find an doctor profile, first select a location from the home page and then search.

If you can't find the page you're looking for using the navigation above, please Contact Us.

 
The Selection Process

In making selections for Super Doctors, MSP Communications employs a rigorous multi-step process designed to identify healthcare providers who have attained a high degree of peer recognition and professional achievement. Super Doctors is a selective yet diverse listing of outstanding doctors, representing consumer-oriented medical specialties.

Read more…


Knee Injections for Arthritis? Save Your Money, Study Says

It's not good news for baby boomers with arthritic knees: Injections of hyaluronic acid have little effect on pain and no effect on function, according to a new analysis. Worse, the injections may cause serious harm, Swiss researchers found.

Read more.

Intensive Care Units for Newborns in Nine States See Sharp Drop in Bloodstream Infections

Central line associated bloodstream infections (CLABSIs) in newborns were reduced by 58 percent in less than a year in hospital neonatal intensive care units (NICUs) participating in an Agency for Healthcare Research and Quality patient safety program.

Read more.

National Academy of Medicine Launches Action Collaborative to Counter Opioid Epidemic; Public-Private Partnership Will Coordinate Initiatives Across Sectors to Drive Collective Solutions

The National Academy of Medicine (NAM), in partnership with the Aspen Institute, launched a public-private partnership called the NAM Action Collaborative on Countering the U.S. Opioid Epidemic.

Read more.

FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

Today, the U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils (a subset of white blood cells) in the body and reduce the risk of infection. The product is intended for use in adults and pediatric patients 12 years and older with blood cancers planned for umbilical cord blood transplantation following a myeloablative conditioning regimen (treatment such as radiation or chemotherapy). 

Read more.

What is Super Doctors?
Super Doctors Magazine

Super Doctors identifies top doctors as selected by their peers and the independent research of MSP Communications. Please note: Doctors cannot pay to be included on Super Doctors® listings nor are they paid to provide input.

Super Doctors is published online and also in print as a special advertising section in leading newspapers and city and regional magazines.

Click here for more details



Browse Super Doctors
Browse Medical Specialties

More ...

Browse
Locations

More ...